The expanding landscape of Deltex: signaling crosstalk and clinical implications.
TL;DR
Current knowledge and emerging insights on Dx are consolidated, providing a framework to guide future research and therapeutic exploration, and important gaps remain in understanding of Dx substrates, molecular mechanisms, and their full spectrum of physiological and pathological roles.
Abstract
The deltex (DTX) gene family encodes RING-type E3 ubiquitin ligases that are central to the regulation of the Notch signaling pathway, a mechanism governing cell fate, differentiation, proliferation, and apoptosis during development and adult tissue homeostasis. In Drosophila melanogaster, the Deltex (Dx) fine-tunes Notch signaling by modulating receptor endocytosis and degradation, acting as either an enhancer or a suppressor depending on the context. Insights from flies have revealed the evolutionary conservation of the Dx-Notch interaction across species, including humans. However, recent studies have expanded this view, identifying Dx as a regulator of multiple signaling pathways beyond Notch, specifically Wingless, Decapentaplegic, and Toll, underscoring its role as a hub for cellular communication. Through its broad regulatory network, Dx influences fundamental processes including cell growth, differentiation, apoptosis, and homeostasis. Dysregulation of Dx expression and function has been implicated in several diseases, ranging from cancer to immunological disorders and congenital abnormalities, positioning it as a promising therapeutic target. Despite these advances, important gaps remain in our understanding of Dx substrates, molecular mechanisms, and their full spectrum of physiological and pathological roles. Future research will be crucial to uncovering the broader biology of DTX family proteins and enabling their clinical application as diagnostic and prognostic markers. This review consolidates current knowledge and emerging insights on Dx, providing a framework to guide future research and therapeutic exploration.